US 11274149
Anti-CD100 antibodies and methods for using the same
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 11274149 (Anti-CD100 antibodies and methods for using the same) held by VACCINEX, INC. expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61K39/0001, A61K39/3955